Virtual screening for natural CETP inhibitors by structure-based pharmacophore.
- Author:
Xiao-qian HUO
;
Lian-sheng QIAO
;
Lu-di JIANG
;
Yu-su HE
;
Gong-yu LI
;
Yan-ling ZHANG
- Publication Type:Journal Article
- MeSH:
Cholesterol Ester Transfer Proteins;
antagonists & inhibitors;
Drug Evaluation, Preclinical;
methods;
Medicine, Chinese Traditional;
Molecular Docking Simulation
- From:
China Journal of Chinese Materia Medica
2015;40(15):3063-3067
- CountryChina
- Language:Chinese
-
Abstract:
Cholesterol ester transfer protein (CETP) is a key regulator of high density lipoprotein (HDL). Owing to its important role in the reverse of cholesterol transport, CETP has become a hotspot target in modulating lipid drug design. In this paper, structure based pharmacophore (SBP) models for CETP inhibitors were built based on the protein structure 4F2A from Protein Database (PDB). The best pharmacophore contained six hydrophobic features, one hydrogen bond acceptor feature and nine excluded volume features, with the N and CAI value was 3.33 and 2.31 respectively. Then the model was used to search the traditional Chinese medicine database (TCMD) and 629 compounds originated from 315 TCM herbs were obtained. Molecular docking was also used to validate SBP by analyzing the critical amino acid residue and the interaction between potential active compounds and receptor. In this study, several TCM herbs, like Lycii Frutus and Schisandrae chinensis fructus, which contained more optimal SBP based screening results, have been reported hypolipidemic effect, and need to be studied deeply in a more focused research on herbal active constituents. Therefore, this study could provide reliable fundamental data for exploring the action mechanisms of TCM, and be applicable to identify lead candidates, which can be utilized as starting scaffolds for natural CETP inhibitors.
